lu 135252 has been researched along with bradykinin in 1 studies
Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
196 | 13 | 14 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | lu 135252 (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Epelde, F; Heras, M; Pérez-Villa, F; Rigol, M; Roig, E; Roqué, M; Sanz, G; Solanes, N | 1 |
1 other study(ies) available for lu 135252 and bradykinin
Article | Year |
---|---|
Enalaprilat, losartan and LU 135252 in coronary blood flow regulation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Coronary Circulation; Enalaprilat; Female; Losartan; Male; Phenylpropionates; Pyrimidines; Swine | 2003 |